Stock-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2023

Share-Based Payment Arrangement [Abstract]

Schedule of Weighted-average Assumptions to Determine Fair Value

The weighted-average assumptions utilized to determine the fair value of options granted to employees are presented in the following table:

	Year Ended December 31,
	2023		2022		2021
Expected volatility	63.1	%	53.3	%	52.1	%
Weighted-average risk-free interest rate	3.75	%	2.72	%	1.07	%
Expected dividend yield	—		—		—
Expected life – in years	6		6		6

Schedule of Option Activity

A summary of the Company’s option activity under 2021 Plan and the 2019 Plan as of December 31, 2023, and changes during the year then ended are as follows:

	Number of Options	Weighted-Average Exercise Price (per share)		Weighted-Average Remaining Contractual Term (in years)
Outstanding at December 31, 2022	6,865,265	$	4.82	7.68
Granted	2,666,034	9.17
Exercised	(1,917,922)	1.16
Forfeited	(437,883)	10.72
Outstanding at December 31, 2023	7,175,494	7.02		7.78
Options exercisable at December 31, 2023	3,446,173	3.91		6.49

Schedule of RSU Activity

A summary of RSU activity under the Company’s 2021 Plan for the year ended December 31, 2023 is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value		Aggregate Fair Value
Unvested balance at January 1, 2023	1,269,743	$	11.97	$	15,194
Granted	1,984,086	9.08		18,016
Vested	(509,102)	12.02		6,119
Forfeited	(173,409)	12.81		2,221
Unvested balance as of December 31, 2023	2,571,318	$	9.88	$	25,405

Schedule of PSU Activity

A summary of PSU activity under the Company’s 2021 Plan for the year ended December 31, 2023 is as follows:

	Number of Shares	Weighted-Average Grant Date Fair Value		Aggregate Fair Value
Unvested balance at January 1, 2023	1,283,620	$	11.22	$	14,402
Granted	—	—		—
Vested	(5,226)	10.05		53
Forfeited	(200,668)	11.96		2,400
Unvested balance at December 31, 2023	1,077,726	$	11.61	$	12,512

Schedule of Stock-based Compensation Expense

The following table shows stock-based compensation expense by where the stock-based compensation expense is recorded by line item in the Company’s consolidated statement of operations:

	For the Year Ended December 31,
	2023		2022		2021
Cost of revenue	$	130	$	74	$	37
Sales and marketing	3,077		2,235		405
Research and development	2,213		1,123		348
General and administrative	9,917		3,961		1,952
Total stock-based compensation	$	15,337	$	7,393	$	2,742